Next Article in Journal
Therapeutic Effects of Combined 6-Shogaol and Ibudilast on Neuroinflammation and Behavioral Deficits in a Cuprizone Mouse Model of Multiple Sclerosis
Next Article in Special Issue
Recent Advances in Pyrazole-Based Cholinesterase Inhibitors: Medicinal Chemistry Perspectives from 2020 to 2025
Previous Article in Journal
Ylang Ylang Essential Oil in Malignant and Non-Malignant Cells: Comparative Mitophagy-Related Transcriptional Responses
Previous Article in Special Issue
Design and Synthesis of 4-Arylazo Pyrazole Carboxamides as Dual AChE/BChE Inhibitors: Kinetic and In Silico Evaluation
 
 
Article

Article Versions Notes

Pharmaceuticals 2026, 19(7), 1003; https://doi.org/10.3390/ph19071003
Action Date Notes Link
article html file updated 4 September 2026 03:55 CEST Update https://www.mdpi.com/1424-8247/19/7/1003/html
article html file updated 9 July 2026 19:30 CEST Update -
article html file updated 8 July 2026 10:08 CEST Original file -
article pdf uploaded. 8 July 2026 10:07 CEST Updated version of record https://www.mdpi.com/1424-8247/19/7/1003/pdf
article xml uploaded. 8 July 2026 10:07 CEST Update https://www.mdpi.com/1424-8247/19/7/1003/xml
article xml file uploaded 8 July 2026 10:07 CEST Original file -
article supplementary file uploaded. 28 June 2026 12:10 CEST - https://www.mdpi.com/1424-8247/19/7/1003#supplementary
article pdf uploaded. 28 June 2026 12:10 CEST Version of Record https://www.mdpi.com/1424-8247/19/7/1003/pdf-vor
Back to TopTop